APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 25 filers reported holding APTEVO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,634 | -77.4% | 11,013 | 0.0% | 0.00% | – |
| Q2 2023 | $16,079 | -28.3% | 11,013 | 0.0% | 0.00% | – |
| Q1 2023 | $22,412 | -14.6% | 11,013 | -2.7% | 0.00% | – |
| Q4 2022 | $26,246 | -54.0% | 11,313 | -39.9% | 0.00% | – |
| Q3 2022 | $57,000 | -28.8% | 18,814 | -15.5% | 0.00% | – |
| Q2 2022 | $80,000 | -73.3% | 22,272 | -56.4% | 0.00% | – |
| Q1 2022 | $300,000 | -66.0% | 51,096 | -54.4% | 0.00% | – |
| Q4 2021 | $883,000 | +419.4% | 112,155 | +917.0% | 0.00% | – |
| Q3 2021 | $170,000 | -9.1% | 11,028 | +31.9% | 0.00% | – |
| Q2 2021 | $187,000 | +92.8% | 8,364 | +163.4% | 0.00% | – |
| Q1 2021 | $97,000 | -18.5% | 3,175 | -2.3% | 0.00% | – |
| Q4 2020 | $119,000 | +3866.7% | 3,251 | +691.0% | 0.00% | – |
| Q3 2020 | $3,000 | -95.8% | 411 | -95.2% | 0.00% | – |
| Q2 2020 | $71,000 | +7000.0% | 8,558 | +2146.2% | 0.00% | – |
| Q1 2020 | $1,000 | – | 381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $39,477,000 | 7.86% |
| RTW INVESTMENTS, LP | 281,402 | $6,312,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 187,995 | $4,217,000 | 0.09% |
| Anson Funds Management LP | 35,587 | $798,000 | 0.08% |
| Alyeska Investment Group, L.P. | 139,172 | $3,122,000 | 0.04% |
| Dynamic Technology Lab Private Ltd | 14,022 | $315,000 | 0.03% |
| JBF Capital, Inc. | 3,907 | $88,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 15,350 | $344,000 | 0.01% |
| Renaissance Technologies | 159,923 | $3,587,000 | 0.00% |
| QS Investors, LLC | 15,650 | $352,000 | 0.00% |